Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadi Mostafaei

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Critical Reviews in Oncology/Hematology|December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomesEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
Minerva Urology and Nephrology|September 30, 2020
Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancerFahad Quhal, Benjamin Pradere, Reza Sari Motlagh, et al.
Oncotargets and Therapy|January 25, 2021
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic TargetsNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
World Journal of Urology|October 21, 2021
Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approachEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
Expert Opinion on Pharmacotherapy|November 28, 2022
Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyondAlberto Bianchi, Markus von Deimling, Maximilian Pallauf, et al.
European Urology|August 22, 2022
Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysisTakafumi Yanagisawa, Pawel Rajwa, Constance Thibault, et al.
Urologic Oncology|September 23, 2020
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D Andrea, et al.
Minerva Urology and Nephrology|March 26, 2021
Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
The Journal of Urology|January 21, 2022
<i>En Bloc</i> Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and HistopathologyTakafumi Yanagisawa, Keiichiro Mori, Reza Sari Motlagh, et al.
Translational Andrology and Urology|March 15, 2021
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Critical Reviews in Oncology/Hematology|December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomesEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
Minerva Urology and Nephrology|September 30, 2020
Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancerFahad Quhal, Benjamin Pradere, Reza Sari Motlagh, et al.
Oncotargets and Therapy|January 25, 2021
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic TargetsNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
World Journal of Urology|October 21, 2021
Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approachEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
Expert Opinion on Pharmacotherapy|November 28, 2022
Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyondAlberto Bianchi, Markus von Deimling, Maximilian Pallauf, et al.
European Urology|August 22, 2022
Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysisTakafumi Yanagisawa, Pawel Rajwa, Constance Thibault, et al.
Urologic Oncology|September 23, 2020
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D Andrea, et al.
Minerva Urology and Nephrology|March 26, 2021
Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
The Journal of Urology|January 21, 2022
<i>En Bloc</i> Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and HistopathologyTakafumi Yanagisawa, Keiichiro Mori, Reza Sari Motlagh, et al.
Translational Andrology and Urology|March 15, 2021
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
Pageof 14